Antibodies against KDR, their production and uses

Details for Australian Patent Application No. 2002334135 (hide)

Owner UCB Pharma S.A.

Inventors Zinkewich-peotti, Karen; Popplewell, Andrew George; Tickle, Simon Peter; Morrison, Robert Kendall

Agent Freehills

Pub. Number AU-B-2002334135

PCT Number PCT/GB02/04619

PCT Pub. Number WO2003/031475

Priority 0124317.9 10.10.01 GB

Filing date 10 October 2002

Wipo publication date 22 April 2003

Acceptance publication date 8 January 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 0124317.9 10.10.01 GB

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002334135

6 March 2008 Assignment before Grant

  Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

8 January 2009 Application Accepted

  Published as AU-B-2002334135

29 January 2009 Corrigenda

  Applications Accepted - Name Index Under the name UCB Pharma S.A., Application No. 2002334135, under INID(72), correct the co-inventor name to Zinkewich-Peotti, Karen

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334136-EARLY HYDROCARBON PRODUCTION SYSTEM

2002334134-LOGIC CIRCUIT FOR PERFORMING MODULAR MULTIPLICATION AND EXPONENTIATION